Table 1.
Patients presenting to Parkland and UT Southwestern with small‐cell/neuroendocrine tumor of the head and neck region
| Age at diagnosis | Race | Sex | Primary site | Listed AJCC stage | Modality | 1st course Rx summary | Date of diagnosis to last contact | Vital status |
|---|---|---|---|---|---|---|---|---|
| Parkland hospital cases | ||||||||
| 63 | Black | M | Glottis | 4A (T4a N0 M0) | Small‐cell carcinoma, NOS | Surgery, Radiation | 1/6/2013‐05/15/2013 | Deceased (cancer) |
| 68 | Black | M | Supraglottis | 4C (T2 N2c M1) | Small‐cell neuroendocrine carcinoma | Chemotherapy | 2/29/12‐11/28/2013 | Deceased (cancer) |
| 56 | White | M | Tonsillar fossa | Not available | Combined small‐cell carcinoma | Surgery, radiation, chemotherapy | 10/26/2001‐07/11/2003 | Deceased (cancer) |
| 47 | White | M | Parotid gland | 4 (T1 N2 M0) | Neuroendocrine carcinoma, NOS | Surgery | 6/16/1997‐02/01/2014 | Alive |
| 23 | White, Hispanic | M | Nasal cavity | Not available | Neuroendocrine carcinoma, NOS | Radiation and chemotherapy | 11/12/1999‐07/07/2003 | Alive |
| 21 | White | F | Supraglottis | 4C (T4a N2 M1) | Neuroendocrine carcinoma, NOS | chemotherapy | 5/20/2014‐02/05/2015 | Deceased (cancer) |
| 44 | White | F | Nasal cavity | 4C (T3 N2c M1) | Neuroendocrine carcinoma, NOS | Surgery | 4/20/2011‐07/14/2011 | Deceased (cancer) |
| UT Southwestern cases | ||||||||
| 81 | White | M | Parotid gland | 4A (T4a N2 M0) | Small‐cell carcinoma, NOS | Surgery | 09/16/2003‐12/18/2003 | Deceased (cancer) |
| 68 | White | F | Nasopharynx | 2 (T1 NX M0) | Adenocarcinoma with neuroendocrine differentiation | Surgery, radiation | 02/13/2006‐01/24/2014 | Alive |
| 78 | White | M | Parotid gland | Not available | Primitive neuroectodermal tumor, NOS | Surgery, radiation, chemotherapy | 12/14/2011‐06/18/2014 | Alive |
| 71 | White | F | Tongue anterior 2/3 | 1 (T1 N1 M0) | Neuroendocrine carcinoma, NOS | Surgery, radiation, chemotherapy | 01/31/2012‐02/11/2014 | Alive |